ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Tom Harkin Is New Chairman f Senate Labor-HS-Education Subcommittee

January 13, 1989

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

All 59 CCOP Awards Announced Heavy In Northeast, Fair In Midwest; Amounts, Priority Scores Listed

June 3, 1983

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

NCI Communications Office to contract Media Campaigns

October 22, 1993